4.6 Article

Defining the Residual Vision in Leber Congenital Amaurosis Caused by RPE65 Mutations

Journal

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Volume 50, Issue 5, Pages 2368-2375

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC
DOI: 10.1167/iovs.08-2696

Keywords

-

Categories

Funding

  1. Macula Vision Research Foundation
  2. Hope for Vision
  3. Foundation Fighting Blindness
  4. Chatlos Foundation
  5. Ruth and Milton Steinbach Fund
  6. Research to Prevent Blindness
  7. National Institutes of Health/National Eye Institute [U10-EY017280]

Ask authors/readers for more resources

PURPOSE. To quantify the residual vision in Leber congenital amaurosis (LCA) caused by RPE65 mutations. METHODS. Patients with RPE65-LCA (n = 30; ages, 4-55) were studied using electroretinography (ERG), full-field stimulus testing (FST), kinetic and static threshold perimetry, and optical coherence tomography (OCT). RESULTS. All patients with RPE65-LCA had abnormal ERGs even at the youngest ages. There were no detectable rod ERGs and only reduced cone ERGs. By chromatic FST, however, 59% of patients had measurable rod-and cone-mediated function. The remaining 41% had only cone-mediated function. Extent of kinetic fields varied widely in the first two decades of life but, by the end of the third decade, there was very little measurable field. Regional patterns of visual loss were evident using dark-adapted static threshold perimetry. The mildest dysfunctions showed relatively homogeneous sensitivity loss beyond the central field. Mid-peripheral dysfunction was a later feature; finally, only central and peripheral islands remained. Colocalized measures of visual function and retinal structure by OCT showed that visual function was detectable when a photoreceptor layer was detectable. CONCLUSIONS. Residual rod as well as cone function is detectable in RPE65-LCA. The finding of different regional patterns of visual loss in these patients suggests that the optimal retinal site(s) for subretinal gene delivery to achieve efficacy are likely to change with disease progression. (Invest Ophthalmol Vis Sci. 2009;50:2368-2375) DOI:10.1167/iovs.08-2696

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available